BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28694201)

  • 21. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
    Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
    Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests.
    Powell RD; Whitworth WC; Bernardo J; Moonan PK; Mazurek GH
    PLoS One; 2011; 6(6):e20061. PubMed ID: 21687702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients.
    Shima K; Sakagami T; Tanabe Y; Aoki N; Moro H; Koya T; Kagamu H; Hasegawa T; Suzuki E; Narita I
    J Infect Chemother; 2014 Jan; 20(1):52-6. PubMed ID: 24462426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
    Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial interferon-gamma release assays during treatment of active tuberculosis in young adults.
    Lee SW; Lee CT; Yim JJ
    BMC Infect Dis; 2010 Oct; 10():300. PubMed ID: 20950477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors That Contribute to Indeterminate Results From the QuantiFERON-TB Gold In-Tube Test in Patients With Inflammatory Bowel Disease.
    Kaur M; Singapura P; Kalakota N; Cruz G; Shukla R; Ahsan S; Tansel A; Thrift AP; El-Serag HB
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1616-1621.e1. PubMed ID: 29175527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indeterminate results of QuantiFERON-TB Gold in-tube due to high nil concentration and methodological exploration and improvement.
    Peng W; Wu S; Chen W; Zhang Y; Fu J; Qiu L; Wang W
    Clin Chim Acta; 2022 Aug; 533():8-14. PubMed ID: 35697122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.
    Barcellini L; Borroni E; Brown J; Brunetti E; Campisi D; Castellotti PF; Codecasa LR; Cugnata F; Di Serio C; Ferrarese M; Goletti D; Lipman M; Rancoita PM; Russo G; Tadolini M; Vanino E; Cirillo DM
    Eur Respir J; 2016 Nov; 48(5):1411-1419. PubMed ID: 27390280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concordance between tuberculin skin test and interferon-γ assay and interferon-γ response to mitogen in pediatric tuberculosis contacts.
    Thomas B; Pugalenthi A; Patel H; Woltmann G; Bankart J; Hoskyns W
    Pediatr Pulmonol; 2011 Dec; 46(12):1225-32. PubMed ID: 21681979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer) using QuantiFERON
    Bernitz N; Clarke C; Roos EO; Goosen WJ; Cooper D; van Helden PD; Parsons SDC; Miller MA
    Vet Immunol Immunopathol; 2018 Feb; 196():48-52. PubMed ID: 29695324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case Report: Disseminated
    Kashihara E; Fujita K; Uchida N; Yamamoto Y; Mio T; Koyama H
    Am J Trop Med Hyg; 2019 Nov; 101(5):1066-1069. PubMed ID: 31549614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan.
    Yi L; Sasaki Y; Nagai H; Ishikawa S; Takamori M; Sakashita K; Saito T; Fukushima K; Igarashi Y; Aono A; Chikamatsu K; Yamada H; Takaki A; Mori T; Mitarai S
    Sci Rep; 2016 Jul; 6():30617. PubMed ID: 27470684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance Evaluation of a New Automated Chemiluminescent Immunoanalyzer-Based Interferon-Gamma Releasing Assay AdvanSure I3 in Comparison With the QuantiFERON-TB Gold In-Tube Assay.
    Kim JJ; Park Y; Choi D; Kim HS
    Ann Lab Med; 2020 Jan; 40(1):33-39. PubMed ID: 31432637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway.
    Pullar ND; Steinum H; Tonby K; Heggelund L; Leiva RA; Ofstad R; Bruun JN; Dyrhol-Riise AM
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):180-7. PubMed ID: 24429310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey.
    Sato R; Nagai H; Matsui H; Kawabe Y; Takeda K; Kawashima M; Suzuki J; Ohshima N; Masuda K; Yamane A; Tamura A; Akagawa S; Ohta K
    J Infect; 2016 Jun; 72(6):706-712. PubMed ID: 27025204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated nontuberculous mycobacterial infection in a patient with idiopathic CD4 lymphocytopenia and IFN-γ neutralizing antibodies: a case report.
    Goto R; Shiota S; Kaimori R; Horinouchi N; Utsunomiya Nishimizu R; Yamamoto K; Miyazaki E
    BMC Infect Dis; 2023 Jan; 23(1):58. PubMed ID: 36717786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a new tuberculosis-related interferon gamma release assay for tuberculosis infection diagnosis in Huzhou, eastern China.
    Qian F; Wang W; Qiu Z; Shen Y; He J; Li D; Zhong J; Dai L
    Indian J Pathol Microbiol; 2013; 56(2):125-8. PubMed ID: 24056648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IFN-γ promoter polymorphisms do not affect QuantiFERON® TB Gold In-Tube test results in a Canadian population.
    Kiazyk S; Larcombe L; Lopez C; Matyas S; Mesa C; Orr P; Juno J; Waruk J; Sharma M; Ball TB
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):1647-1652. PubMed ID: 28000585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adapted T cell interferon-gamma release assay for the diagnosis of pleural tuberculosis.
    Ates G; Yildiz T; Ortakoylu MG; Ozekinci T; Erturk B; Akyildiz L; Caglar E
    Respiration; 2011; 82(4):351-7. PubMed ID: 21293103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.